GeneReach Biotechnology Correlations

Stocks . Taiwan . 
Stock . GeneReach Biotechnology
4171 Stock  TWD 24.95  0.50  1.96%   
The current 90-days correlation between GeneReach Biotechnology and First Insurance Co is -0.06 (i.e., Good diversification). The correlation of GeneReach Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

GeneReach Biotechnology Correlation With Market

Average diversification

The correlation between GeneReach Biotechnology and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to GeneReach Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneReach Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneReach Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneReach Biotechnology to buy it.

Moving together with GeneReach Stock

  0.644743 Oneness BiotechPairCorr
  0.612330 Taiwan SemiconductorPairCorr
  0.630050 YuantaP shares TaiwanPairCorr
  0.640053 YuantaP shares TaiwanPairCorr
  0.640057 Fubon MSCI TaiwanPairCorr

Moving against GeneReach Stock

  0.636266 Top Union ElectronicsPairCorr
  0.556547 Medigen Vaccine BiologicsPairCorr
  0.533481 Innolux CorpPairCorr
  0.482412 Chunghwa TelecomPairCorr
  0.444174 OBI PharmaPairCorr
  0.394147 TaiMed BiologicsPairCorr
  0.382303 United MicroelectronicsPairCorr
  0.381303 Nan Ya PlasticsPairCorr
  0.362603 Evergreen Marine CorpPairCorr
  0.352409 AU OptronicsPairCorr
  0.312609 Yang Ming MarinePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
2852
+ 0.96
2851
5876
+ 0.93
2884
1466
+ 0.9
2852
1466
+ 0.88
2851
2852
+ 0.8
2884
5859
+ 0.8
1466
  
High negative correlations   
1466
- 0.15
5607

Risk-Adjusted Indicators

There is a big difference between GeneReach Stock performing well and GeneReach Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GeneReach Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in GeneReach Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

GeneReach Biotechnology Corporate Management

Elected by the shareholders, the GeneReach Biotechnology's board of directors comprises two types of representatives: GeneReach Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GeneReach. The board's role is to monitor GeneReach Biotechnology's management team and ensure that shareholders' interests are well served. GeneReach Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GeneReach Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alison LeeChief OfficerProfile
Grace ChangChief OfficerProfile
David TsaiChief OfficerProfile
Simon ChungChief OfficerProfile
Yuwen HuangDeputy General Manager-Compliance & ProductionProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY